RESULTS	In contrast , rofecoxib when administered only postoperatively did not significantly improve analgesic effects or side-effects at time of assessment of the main criteria ( 24 h after skin closure ) , but during the follow-up period at 48 h and 72 h after skin closure pain scores and morphine consumption were improved compared to placebo .\